Pharmaceutical composition for treating cancer using carbonate apatite nanoparticles
First Claim
Patent Images
1. A pharmaceutical composition, comprising:
- carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a nucleic acid with antitumor activity; and
a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the nucleic acid are dispersed.
2 Assignments
0 Petitions
Accused Products
Abstract
A principal object of the present invention is to provide a pharmaceutical composition that can produce a high antitumor effect by efficiently delivering a drug with antitumor activity to tumor tissues with the aid of carbonate apatite nanoparticles. The present invention provides a pharmaceutical composition including carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a drug with antitumor activity and a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the drug are dispersed.
-
Citations
12 Claims
-
1. A pharmaceutical composition, comprising:
- carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a nucleic acid with antitumor activity; and
a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the nucleic acid are dispersed. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
- carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a nucleic acid with antitumor activity; and
Specification